NCT06800976

Brief Summary

Symptoms that patients attribute to the environment when no environmental cause can be identified are known as "idiopathic environmental intolerance" (IEI). IEI is often associated with a major psychological and socio-professional impact. Specific diagnostic tools and evidence-based treatment programs are still lacking. As a result, IEI patients often feel left behind by physicians and public health policies. A number of environmental agents are singled out by IEI sufferers, including chemicals (cleaning products, tobacco smoke), electromagnetic fields generated by cell phones and base stations, air conditioning and infrasound emitted by wind turbines. Patients hold one or more of these environmental agents responsible for a very wide range of chronic, non-specific physical symptoms such as diffuse pain, fatigue, dizziness, dyspnoea, hot flushes, nausea, tinnitus or palpitations, but also cognitive symptoms such as loss of memory or concentration. However, the medical examination of IEI patients shows no evidence of bodily dysfunction. Furthermore, numerous exposure studies have shown that environmental agents did not alter the biological parameters of IEI patients, that patients could not reliably distinguish between real and fictitious exposures, and that they only presented symptoms when they thought the exposure was real, whether this was true or not. This suggests that IEI symptoms can be considered "functional", resulting from an alteration in the way the body is felt rather than from injury to the body itself. Recently, several authors including Lemogne and Pitron have proposed a cognitive model of body awareness and more specifically of functional physical symptoms.This model is part of a Bayesian understanding of brain function, which is increasingly seen as a process underlying all perceptual experiences.From this perspective, bodily experiences are the result of probabilistic calculations Two sources of information are integrated, weighted by their reliability (accuracy) with regard to the current context: the body's sensory signals on the one hand (i.e. peripheral nerve inputs) and "priors" about the body on the other (i.e. pre-existing information from previous bodily experiences, beliefs about the body, emotions, etc.). In functional physical symptoms, it has been suggested that priors override the body's sensory signals, thus skewing bodily perception.This would be the consequence of an imbalance between low-precision sensory signals on the one hand, and high-precision priors on the other. In line with this model, Van den Bergh and Witthöft have proposed an understanding of IEI as arising from a nocebo effect.Here, we propose a research project with patients suffering from IEI to test and validate this Bayesian theoretical model of IEI, the main study C22-19, BELIEFS which is currently recruiting. This ancillary study, C24-26 BELIEFS-VS, enables us to include a population of healthy volunteers whom we will compare with the IEI patients in the main C22-19 BELIEFS study.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
35mo left

Started Mar 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Mar 2026Mar 2029

First Submitted

Initial submission to the registry

January 24, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 30, 2025

Completed
1.2 years until next milestone

Study Start

First participant enrolled

March 31, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2029

Last Updated

December 5, 2025

Status Verified

November 1, 2025

Enrollment Period

1.2 years

First QC Date

January 24, 2025

Last Update Submit

November 28, 2025

Conditions

Keywords

predictive processingMechanismssymptoms associated with environmental factorsnegative affect

Outcome Measures

Primary Outcomes (2)

  • Performance on the Belief Updating Task

    (Single assessment)

  • Performance on the Affective Picture Paradigm

    (Single assessment)

Secondary Outcomes (10)

  • The Somatic Symptom Disorder - B Criteria Scale

    (Single Assessment)

  • Symptom Interpretation Questionnaire

    (Single Assessment)

  • Modern Health Worries Scale short (12-item) version

    (Single Assessment)

  • Climate Change Anxiety Scale

    (Single Assessment)

  • Hospital Anxiety and Depression scale

    (Single Assessment)

  • +5 more secondary outcomes

Study Arms (1)

Healthy

Healthy participants with no idiopathic environmental intolerance

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We are recruiting healthy participants that will be age- and gender-matched to participants in the BELIEFS study, who live with idiopathic environmental intolerances.

You may qualify if:

  • years of age or older; not suffering from an idiopathic environmental intolerance; informed consent is given.

You may not qualify if:

  • Suffering from a current psychiatric or neurological condition
  • not being fluent in spoken and written French
  • being imprisoned/jailed
  • being hospitalized
  • Persons of legal age who are subject to a legal protection measure (e.g. conservatorship, guardianship), persons of legal age who are unable to express their consent and who are not subject to a protection measure.
  • being pregnant or breast-feeding
  • Translated with DeepL.com (free version)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unité de pathologies professionnelles et environnementales, Hôtel-Dieu

Paris, Île-de-France Region, 75004, France

Location

MeSH Terms

Conditions

Multiple Chemical Sensitivity

Condition Hierarchy (Ancestors)

Environmental IllnessHypersensitivityImmune System DiseasesDisorders of Environmental Origin

Study Officials

  • Cédric Lemogne, Dr.

    APHP Hôtel-Dieu

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Victor Pitron, Dr.

CONTACT

Tara M Petzke, Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2025

First Posted

January 30, 2025

Study Start

March 31, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

March 1, 2029

Last Updated

December 5, 2025

Record last verified: 2025-11

Locations